Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q91816304)
Watch
English
Secondary KIT mutations: the GIST of drug resistance and sensitivity
scientific article published on 22 February 2019
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
editorial
0 references
title
Secondary KIT mutations: the GIST of drug resistance and sensitivity
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
main subject
drug resistance
1 reference
based on heuristic
inferred from title
author
Andrea Napolitano
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
author name string
Bruno Vincenzi
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
publication date
22 February 2019
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
published in
British Journal of Cancer
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
volume
120
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
issue
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
page(s)
577-578
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
cites work
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointesti
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomi
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6461933
retrieved
23 February 2021
Identifiers
DOI
10.1038/S41416-019-0388-7
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
PMC publication ID
6461933
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
PubMed publication ID
30792534
1 reference
stated in
Europe PubMed Central
PMC publication ID
6461933
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30792534%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit